You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
加科思-B(01167.HK)擬配售現有股份及補足認購新股份 總籌1.604億港元
格隆匯 02-10 08:24

格隆匯2月10日丨加科思-B(01167.HK)發佈公吿,2023年2月10日,公司、Yakovpharma Ltd(作為補足賣方)與配售代理訂立配售及認購協議,據此,補足賣方同意出售及配售代理同意(作為補足賣方的代理)按竭誠盡力基準促使買方購買2210.01萬股補足賣方持有的配售股份,價格為每股配售股份7.26港元;及公司有條件同意向補足賣方發行,而補足賣方有條件同意按認購價認購2210.01萬股認購股份,認購價相等於配售價。

認購所得款項總額預期約為1.604億港元。認購所得款項淨額估計約為1.589億港元。公司擬將所得款項淨額的約35%用於推進其KRAS G12C抑制劑JAB-21822的臨牀試驗(包括確證性臨牀試驗);及所得款項淨額的約65%用於推進其臨牀前管線產品的研究和開發,包括開發JAB-23400(多KRAS抑制劑)及其iADC平台等項目。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account